Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Change in Other Operating Liabilities (2022 - 2025)

Updated

Adaptin Bio (APTN) recorded Change in Other Operating Liabilities of -$44,750 in Q4 2024, compared with $4,250 a year earlier.

Analysis

Adaptin Bio (APTN) Change in Other Operating Liabilities (2022 - 2025) Analysis & Trends

For FY2024, Adaptin Bio reported Change in Other Operating Liabilities of -$32,000.

  • Across earlier years, Change in Other Operating Liabilities came in at $17,000 in FY2023 (+13.3%) and $15,000 in FY2022.
  • Per Business Quant, the preceding three quarters came in at $4,250 (Q3 2024), $4,250 (Q2 2024) and $4,250 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.69 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -113.00 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -4,746.00
Dec 31, 2024 -44,750.00
Sep 30, 2024 4,250.00
Jun 30, 2024 4,250.00
Mar 31, 2024 4,250.00
Dec 31, 2023 4,250.00
Sep 30, 2023 4,250.00
Jun 30, 2023 4,250.00
Mar 31, 2023 4,250.00
Dec 31, 2022 4,250.00
API Access

Adaptin Bio Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=APTN&period=max&api_key=YOUR_API_KEY